FR3120790B1 - Association d’un extrait de myrte et d’un extrait de Tripterygium wilfordii pour lutter contre l’inflammation induite par C. acnes - Google Patents
Association d’un extrait de myrte et d’un extrait de Tripterygium wilfordii pour lutter contre l’inflammation induite par C. acnes Download PDFInfo
- Publication number
- FR3120790B1 FR3120790B1 FR2102343A FR2102343A FR3120790B1 FR 3120790 B1 FR3120790 B1 FR 3120790B1 FR 2102343 A FR2102343 A FR 2102343A FR 2102343 A FR2102343 A FR 2102343A FR 3120790 B1 FR3120790 B1 FR 3120790B1
- Authority
- FR
- France
- Prior art keywords
- extract
- acnes
- combination
- tripterygium wilfordii
- inflammation induced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000186427 Cutibacterium acnes Species 0.000 title abstract 2
- 206010061218 Inflammation Diseases 0.000 title abstract 2
- 240000005125 Myrtus communis Species 0.000 title abstract 2
- 235000013418 Myrtus communis Nutrition 0.000 title abstract 2
- 241000830536 Tripterygium wilfordii Species 0.000 title abstract 2
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- 235000015398 thunder god vine Nutrition 0.000 title abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/04—Plant cells or tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Birds (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne une association comprenant un extrait de myrte et un extrait de Tripterygium wilfordii, notamment pour son utilisation dans le traitement de l’inflammation induite par C. acnes et dans le traitement d’une peau acnéique.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2102343A FR3120790B1 (fr) | 2021-03-10 | 2021-03-10 | Association d’un extrait de myrte et d’un extrait de Tripterygium wilfordii pour lutter contre l’inflammation induite par C. acnes |
PCT/FR2022/050431 WO2022189758A1 (fr) | 2021-03-10 | 2022-03-10 | Association d'un extrait de myrte et d'un extrait de tripterygium wilfordii pour lutter contre l'inflammation induite par c. acnes |
BR112023018212A BR112023018212A2 (pt) | 2021-03-10 | 2022-03-10 | Combinação de um extrato de murta e extrato de tripterygium wilfordii para combater a inflamação induzida por c. acnes |
MX2023010417A MX2023010417A (es) | 2021-03-10 | 2022-03-10 | Combinacion de extracto de mirto y extracto de tripterygium wilfordii para combatir la inflamacion inducida por c. acnes. |
CA3210267A CA3210267A1 (fr) | 2021-03-10 | 2022-03-10 | Association d'un extrait de myrte et d'un extrait de tripterygium wilfordii pour lutter contre l'inflammation induite par c. acnes |
US18/281,088 US20240165185A1 (en) | 2021-03-10 | 2022-03-10 | Combination of a myrtle extract and a tripterygium wilfordii extract for combating c. acnes-induced inflammation |
EP22714228.8A EP4304622A1 (fr) | 2021-03-10 | 2022-03-10 | Association d'un extrait de myrte et d'un extrait de tripterygium wilfordii pour lutter contre l'inflammation induite par c. acnes |
CN202280032273.7A CN117241814A (zh) | 2021-03-10 | 2022-03-10 | 用于控制痤疮丙酸杆菌引起的炎症的桃金娘提取物和雷公藤提取物的组合 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2102343 | 2021-03-10 | ||
FR2102343A FR3120790B1 (fr) | 2021-03-10 | 2021-03-10 | Association d’un extrait de myrte et d’un extrait de Tripterygium wilfordii pour lutter contre l’inflammation induite par C. acnes |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3120790A1 FR3120790A1 (fr) | 2022-09-23 |
FR3120790B1 true FR3120790B1 (fr) | 2024-03-15 |
Family
ID=75539592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR2102343A Active FR3120790B1 (fr) | 2021-03-10 | 2021-03-10 | Association d’un extrait de myrte et d’un extrait de Tripterygium wilfordii pour lutter contre l’inflammation induite par C. acnes |
Country Status (8)
Country | Link |
---|---|
US (1) | US20240165185A1 (fr) |
EP (1) | EP4304622A1 (fr) |
CN (1) | CN117241814A (fr) |
BR (1) | BR112023018212A2 (fr) |
CA (1) | CA3210267A1 (fr) |
FR (1) | FR3120790B1 (fr) |
MX (1) | MX2023010417A (fr) |
WO (1) | WO2022189758A1 (fr) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2783425B1 (fr) | 1998-09-17 | 2002-06-07 | Fabre Pierre Dermo Cosmetique | Extrait de myrte titre en myrtucommulone b', son procede de preparation et son application en dermatologie et en cosmetologie |
FR2992862B1 (fr) | 2012-07-09 | 2014-10-03 | Fabre Pierre Dermo Cosmetique | Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes |
FR3051116B1 (fr) * | 2016-05-12 | 2019-06-07 | Pierre Fabre Dermo-Cosmetique | Procede de production du celastrol et de derives triterpeniques pentacycliques |
-
2021
- 2021-03-10 FR FR2102343A patent/FR3120790B1/fr active Active
-
2022
- 2022-03-10 MX MX2023010417A patent/MX2023010417A/es unknown
- 2022-03-10 US US18/281,088 patent/US20240165185A1/en active Pending
- 2022-03-10 CA CA3210267A patent/CA3210267A1/fr active Pending
- 2022-03-10 EP EP22714228.8A patent/EP4304622A1/fr active Pending
- 2022-03-10 WO PCT/FR2022/050431 patent/WO2022189758A1/fr active Application Filing
- 2022-03-10 BR BR112023018212A patent/BR112023018212A2/pt unknown
- 2022-03-10 CN CN202280032273.7A patent/CN117241814A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
FR3120790A1 (fr) | 2022-09-23 |
US20240165185A1 (en) | 2024-05-23 |
WO2022189758A1 (fr) | 2022-09-15 |
EP4304622A1 (fr) | 2024-01-17 |
MX2023010417A (es) | 2023-09-18 |
CA3210267A1 (fr) | 2022-09-15 |
BR112023018212A2 (pt) | 2023-10-03 |
CN117241814A (zh) | 2023-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2021001292A1 (es) | Terapia de combinación que incluye un inhibidor de krasg12c y uno o más agentes farmacéuticamente activos adicionales para el tratamiento de cánceres | |
MX2018005096A (es) | Combinaciones de gemcabeno para el tratamiento de enfermedad cardiovascular. | |
BR112016019592A8 (pt) | Composto, uso de um composto, e, composição farmacêutica | |
WO2015054619A3 (fr) | Utilisation d'un inhibiteur de pcsk9 pour traiter l'hyperlipidémie | |
MA39094A1 (fr) | Polythérapie comprenant un inhibiteur de mdm2 et un ou plusieurs principes pharmaceutiquement actifs supplémentaires pour le traitement de cancers | |
ECSP12012349A (es) | Agentes inductores de apoptosis contra el cáncer y de enfermedades inmunes y autoinmunes | |
ECSP12012348A (es) | Agentes inductores de apoptosis contra el cáncer y de enfermedades inmunes y autoinmunes | |
MA38986A3 (fr) | Inhibiteurs marqués de l'antigène membranaire spécifique de la prostate (psma), leur utilisation comme agents d'imagerie et agents pharmaceutiques pour le traitement du cancer de la prostate | |
EA201590368A1 (ru) | Синергетическая фунгицидная композиция | |
FR3021970B1 (fr) | Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs | |
MA47736B1 (fr) | Pyrimidopyrimidinones utiles en tant qu'inhibiteurs de la kinase wee-1 | |
MA35638B1 (fr) | 2-thiopyrimidinones | |
MX2018003291A (es) | Nuevas estrategias terapeuticas contra el cáncer de sangre. | |
MA38253A1 (fr) | Compositions comprenant de la vortioxétine et du donépézil | |
ITFI20110166A1 (it) | Nuovi fotosensibilizzanti ad uso terapeutico. | |
MA39447B1 (fr) | Pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine | |
MX2020008923A (es) | Inhibidores de la bomba de protones y métodos de uso en inflamación y cicatrización tisular inducida por quimioradiación. | |
MX2020004513A (es) | Cocristales, composiciones farmacéuticas de los mismos y métodos de tratamiento que los implican. | |
FR3120790B1 (fr) | Association d’un extrait de myrte et d’un extrait de Tripterygium wilfordii pour lutter contre l’inflammation induite par C. acnes | |
EA201700052A1 (ru) | Применение в одной пилюле, таблетке, капсуле миноциклина, ациклогуанозина, аторвастатина и витамина d для лечения ревматоидного артрита | |
MA39448A1 (fr) | (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical | |
EP2786765A3 (fr) | Composition pour thérapie de combinaison comprenant un anticorps dirigés contre C-met et un inhibiteur de FGFR | |
MX2021015403A (es) | Terapia de combinacion que comprende un conjugado de anticuerpo-farmaco anti-cd19 y un inhibidor de pi3k o un agente secundario. | |
EA202092045A1 (ru) | Лечение и предупреждение преэклампсии | |
MA51278A (fr) | Utilisation d'un extrait végétal en tant qu'agent actif dans le traitement de maladies dermatologiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20220923 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |